Introduction
Muscle cells, and in particular cardiomyocytes, consume a large amount of chemical energy to produce mechanical work. Myofilament contraction is regulated and synchronized within the cell by rapid, transient changes in the cytosolic Ca 2þ concentration. Most of this calcium is released from the sarcoplasmic reticulum (SR), which has a large surface for Ca 2þ transport, in close contact with the myofilaments. In between the myofilaments, cardiomyocytes are packed with mitochondria. These generate the energy needed for myofilament contraction, but serve also as an additional store for Ca 2þ . Thus, SR and mitochondria interact physiologically to control cellular Ca 2þ homeostasis. It is partly through the Ca 2þ loading of the mitochondria that their energy production is matched with the contractile energy demand.
Mitochondria are now recognized as an essential effector structure determining cell death and survival. This is not only because of their central role in cellular energy metabolism, but also as key players in survival and death signalling. Alterations in the function of the SR are now known to be of primary importance for the development of hypertrophy and heart failure and in the genesis of lifethreatening arrhythmias. Therefore, interaction between SR and mitochondria not only determines cardiomyocyte function under physiological conditions, but also is relevant for the development of cardiomyocyte dysfunction or death under pathophysiological conditions. The present Spotlight Issue of Cardiovascular Research aims to update our understanding of these important and rapidly evolving aspects of cardiac physiology and pathophysiology through a series of invited reviews and original contributions.
Recent advances in sarcoplasmic reticulum physiology
In this issue, Orchard and Brette review the structure and function of t-tubules, their contribution to Ca 2þ transients in cooperation with the SR, and the pathophysiological importance of their remodelling in different conditions. 1 The regulatory mechanisms governing ryanodine receptors and Ca 2þ ATPase (SERCA) are also discussed. Ryanodine receptors are regulated by luminal Ca 2þ and a protein complex in which triadin, calsequestrin, and junctin are involved. Genetic defects in these proteins result in arrhythmia and heart failure, as described in a review by Györke and Terentyev. 2 Nitric oxide derived from nNOS and eNOS also appears to regulate ryanodine receptors, in part by direct nitrosylation according to the nitrosative vs. oxidative balance. This balance can be modulated by the translocation of nNOS from the SR to the sarcolemma in the failing heart, and Lim et al. 3 describe how this could be a target for pharmacological interventions. On the other hand, Periasamy et al. 4 review how changes in the expression and/or activity of SERCA, regulated by phospholamban and sarcolipin, constitute a major regulatory mechanism of intracellular Ca 2þ homeostasis. Along these lines, an original article demonstrates the importance of the phospholamban phosphorylation state to b-adrenergic dysfunction that is observed in various cardiomyopathies. 5 The functional interactions of SERCA with other proteins appear more and more complex; new studies continue to demonstrate the importance of auxiliary proteins that function to stabilize SERCA, as described for sarcalumenin in another original article. 6 Finally, the recent evidence identifying a new pacemaker function of SR as an essential element in the initiation of the cardiac impulse, in close interaction with the classical surface-membrane voltage-gated ion channels, is reviewed in an article by Maltsev and Lakatta. 7 3. The role of the SR in arrhythmia, hypertrophy, and heart failure Although the pacemaker function of the SR has been only recently recognized, its importance in the genesis of certain types of arrhythmias has been known for a long time. How the SR produces Ca 2þ waves in the presence of Ca 2þ overload, what determines that Ca 2þ waves result in arrhythmias, and how potentially lethal, Ca 2þ wavedependent arrhythmias can be treated by interventions aimed at the SR are reviewed by Venetucci et al. 8 A particularly serious type of Ca 2þ wave-dependent arrhythmias
The opinions expressed in this article are not necessarily those of the European Society of Cardiology are those associated with catecholaminergic polymorphic ventricular tachycardia, an inherited disease caused by mutations in the ryanodine receptor or calsequestrin. The molecular mechanisms of this disease and the novel molecular targets proposed for its treatment are the subject of another review article by Lui and Priori. 9 Arrhythmogenesis is responsible for the death of many patients with heart failure. There is solid evidence of the important role of the SR in the pathophysiology of heart failure, but the molecular details of this role remain obscure. The review by George 10 discusses the Ca 2þ leak from the SR due to a defective ryanodine receptor as a cause of arrhythmias and its less-clear role in contractile failure. A proposed mechanism for contractile dysfunction in patients with heart failure is reduced SR Ca 2þ release. Bito et al.
11 explain the importance of crosstalk between sarcolemmal L-type Ca 2þ channels and the SR to ensure adequate Ca 2þ kinetics for every single beat, the beat-to-beat coordination and for a long-term contractile steady state, and the potential mechanisms by which this crosstalk may be altered. An original article describes how Ca 2þ reuptake by the SR may lead to altered contractility in diabetic mice when hypertension and diabetes are also present (a situation reminiscent of the so-called 'metabolic syndrome'). 12 On the other hand, NADPH-derived ROS signalling induced by tachycardia and exercise appears to induce cardioprotection by modulating ryanodine receptors. 13 
Recent news on mitochondria
Despite being the object of an intense research effort, many aspects of mitochondrial structure, function, and role in disease remain unknown. A recent finding was the presence in mitochondrial membranes of connexin43, the protein forming gap junction channels in the sarcolemma of cardiomyocytes. In this issue, the studies demonstrating this new localization, its role in preconditioning protection, and its potential physiological functions are reviewed by Ruiz-Meana et al. 14 The role of mitochondria in death or survival in stressed cells is beginning to be better understood. This issue presents an overview by Gustafsson and Gottlieb 15 of the role of mitochondria as central integrators of multiple stress signals, resulting in altered mitochondrial dynamics (mitochondrial fission and mitophagy) or mitochondrial permeabilization. An original article deals with altered mitochondrial kinetics in response to ceramide. 16 The exact mechanisms by which mitochondria participate in preconditioning protection remain relatively obscure. Recent data suggest that cGMP signalling can play an important role in pre-and postconditioning. This issue includes a review by Costa et al. 17 analysing evidence that protein kinase G brings the protective signal to the outer mitochondrial membrane, where it initiates a protein phosphorylation cascade that propagates across the intermembrane space. This mechanism involves protein kinase C activation and results finally in ROS signalling. The identification of the role of cGMP in cardioprotection is a long story that may have a happy ending. Initial reports demonstrating the protective effects of cGMP on reperfusion injury in isolated cardiomyocytes 18, 19 were followed by preclinical studies showing the cGMP-mediated cardioprotective effect of natriuretic peptides in large animals. 20 A recent, doubleblind, placebo-controlled study in more than 1200 patients has demonstrated that atrial natriuretic peptide reduced infarct size when applied at the time of reperfusion. 21 Original articles in this issue describe other pathways of protection: those involving protein kinase A and mitochondrial Ca 2þ -activated K þ (mitoK Ca ) channels, 22 reduction of complex I-dependent mitochondrial respiration, 23 and the mitochondrial Na þ /H þ exchanger NHE-1. 24 Finally, an original paper demonstrates the importance of mitochondria in vascular biology: mitochondrial uncoupling protein 2 may be responsible for the 'local fever' observed in atherosclerotic plaques. 25 
Sarcoplasmic-reticulum-mitochondrial interactions
Recent studies have demonstrated that mitochondria and SR are tightly connected in cardiac cells, and for certain processes form a functional unit. 26 An original article illustrates a different type of relationship between SR and mitochondria based on ROS signalling and its effect on Ca 2þ sparks. 27 The contribution by Piper et al. 28 summarizes evidence that interactions between SR and mitochondria are also crucial for the pathogenesis of reperfusion injury as Ca 2þ loading and release by one of these organelles can influence the function of the other. This relationship is analysed in relation to the effector mechanisms of cardioprotective signalling.
Summary
The review articles and original contributions clearly demonstrate the increasingly recognized importance of mitochondria and the SR in cardiac pathophysiology and the progressively heightened understanding of interactions between both organelles. We hope that this issue will serve to update the knowledge of cardiovascular scientists in this rapidly moving field, stimulating new research that will not only elucidate the many unanswered questions in the field but will also contribute to reducing the burden of cardiovascular disease.
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